lack relationship hepatotox lithocholic-acid sulfat biliari bile acid chenodiol therapi nation cooper gallston studi hepatotox nation cooper gallston studi patient toxic effect chenodiol se lithochol defect sulfat bile sampl new high-perform liquid chromatographi method proport individu lithochol amid unsulf lithocholylglycin lithocholyltaurin common bile acid amid sampl nation cooper gallston studi patient abnorm light microscop liver biopsi result major aminotransferas elev control group patient similar chenodiol dose evid liver injuri bile sampl healthi subject analyt method percentag chenodiol cholic deoxychol acid high-perform liquid chromatographi previou gas-liquid chromatographi analys sampl nation cooper gallston studi refer laboratori No signific differ gallston patient evid liver injuri percent total lithochol amid percent unsulf lithochol amid percent chenodiol amid lithochol bile sampl mean extent sulfat patient cours therapi mean valu healthi subject similar wide rang extent lithochol sulfat injuri dose chenodiol accumul unsulf lithochol se bile acid injuri enrich bile acid chenodiol lithochol hepatocyt patient hepatotox chang bile-acid metabol feed chenodiol half lithochol amid bile sampl extent sulfat variabl gallston patient healthi subject 